Research Topic · Peer-Reviewed

Oncology Renal Cancer

Renal cancer encompasses malignancies arising in the kidney, the most common being renal cell carcinoma, which originates in the epithelial lining of the renal tubules. Clear cell renal cell carcinoma is the predominant histological subtype and is frequently associated with inactivation of the VHL tumor-suppressor g…

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 11× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Renal cancer encompasses malignancies arising in the kidney, the most common being renal cell carcinoma, which originates in the epithelial lining of the renal tubules. Clear cell renal cell carcinoma is the predominant histological subtype and is frequently associated with inactivation of the VHL tumor-suppressor gene, leading to dysregulated hypoxia-inducible factor signaling and abnormal angiogenesis; papillary and chromophobe carcinomas represent additional distinct subtypes with their own molecular features. Tumors may grow silently within the renal parenchyma and are often discovered incidentally on imaging performed for unrelated reasons, although hematuria, flank pain, or a palpable mass can occur in more advanced disease. Staging integrates tumor size, local invasion, and the presence of nodal or distant metastasis, guiding both prognosis and treatment. Surgical resection, through partial or radical nephrectomy, remains the principal curative approach for localized tumors. Advanced and metastatic disease is managed with agents targeting the vascular endothelial growth factor pathway and the mechanistic target of rapamycin, as well as immune checkpoint inhibitors that restore antitumor immunity. Ongoing research addresses molecular classification, resistance mechanisms, and predictive biomarkers to refine therapy selection and improve survival across the heterogeneous spectrum of renal malignancy.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

Risk Factors Associated with Breast Cancer

Manuel Vargas-Hernández VíctorCorresponding author
Gynecology Service, Hospital Juárez de México; Mexican Academy of Surgery
Hematology and Oncology Research doi:10.14302/issn.2372-6601.jhor-20-3544

How this research is being cited

The 5 articles above have been cited 11 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Oncology Renal Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.